ABBV vs AJG · P/E 81, rev $16.99B vs P/E 33, rev $8.76B
AbbVie Inc (ABBV) versus Arthur J Gallagher & Co (AJG) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Not investment advice. Open the ABBV and AJG stock pages for the full models.
Not investment advice.